“Lucintel’s latest study found that, The future of the global bladder cancer diagnostic market looks promising with opportunities in the hospital, clinic, and cancer center markets. The global bladder cancer diagnostic market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing awareness of bladder related diseases, increasing number of geriatric popuation, and rising demand for advanced diagnostic technologies like computed tomography scan and magnetic resonance imaging.
In this market, urine lab tests, cystoscopy, biopsy, and imaging test are the major segments of bladder cancer diagnostic market by test type.
Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its substantial use for effective biopsy technique and advanced imaging and rising preference for transurethral resection of bladder tumor approach.
Browse in depth TOC of the bladder cancer diagnostic Market
100 – Figures
150-Pages
bladder cancer diagnostic Market is marked by presence of several big and small players. “
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Tags:
BNN, iCN Internal Distribution, Reportedtimes, Extended Distribution, Research Newswire, English